ScienceAlert on MSN
Non-Invasive Brain Stimulation 'Significantly' Improves Depression in Just 10 Days, Trial Finds
(TheDigitalArtist/Pixabay/Canva) Major depressive disorder is the most common mental health issue in the world, affecting ...
FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by ...
Follow the live score and play-by-play updates of the second day of play between India and England at the iconic Lords ...
Chinese startup VeloAlpha uses AI to simulate reactor designs, potentially cutting years of trial and error from nuclear ...
The first container ship to run on Brazilian-made ethanol fuel set sail early on July 14 from the port of Santos, an unprecedented test for the nation’s biofuel industry that marks a key step toward ...
Live Science on MSN
83-year-old man went to the hospital with very itchy skin. Turns out he had a rare form of syphilis
A man went to the emergency room after being in and out of hospitals for a month, and doctors found a surprising explanation ...
Before French blogger Mylene Mathieu visited Hefei, the capital of eastern China's Anhui province, she pictured a city known for Hui-style architecture and traditional culture."Artificial intelligence ...
This Bible is the foundational, American historical document presented during the Revolutionary era, and it’s referenced in ...
At some point England will face the very uncomfortable feeling of life without Joe Root. He will turn 36 this year and even he will one day see his powers wane.
inews.co.uk on MSN
Patients waiting weeks for vital drugs with pharmacy shortages ‘worst in 40 years’
Cardiovascular and epilepsy medications are just some of the drugs that are in short supply across the country ...
Tech Times on MSN
Tau therapy slows Alzheimer's decline in first human trial as AAIC 2026 wraps in London
Alzheimer's treatment 2026 reached an inflection point at AAIC 2026 in London: diranersen showed the first tau-targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results